Skip to main content

Table 4 Hazard ratios

From: Carbonic anhydrase IX and response to postmastectomy radiotherapy in high-risk breast cancer: a subgroup analysis of the DBCG82 b and c trials

  CA IX positive (n = 151) CA IX negative (n = 794)
Overall mortality 0.87 (0.60–1.27) 0.82 (0.69–0.97)
Disease-specific mortality 0.83 (0.55–1.27) 0.76 (0.63–0.93)
Distant metastases 0.83 (0.54–1.25) 0.76 (0.63–0.91)
Locoregional recurrence 0.23 (0.08–0.61) 0.16 (0.09–0.28)
  1. Presented are hazard ratios (95% confidence intervals) of overall mortality, disease-specific mortality, distant metastases and loco-regional recurrence probabilities after postmastectomy radiotherapy in carbonic anhydrase (CA) IX positive and in CA IX negative high-risk breast cancer patients.